Debt-to-equity of Processa Pharmaceuticals, Inc. from 31 Mar 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Processa Pharmaceuticals, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2014 to 30 Sep 2025.
  • Processa Pharmaceuticals, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 39%, a 96% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Processa Pharmaceuticals, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 39% +19% +96% 30 Sep 2025
Q2 2025 41% +25% +153% 30 Jun 2025
Q1 2025 38% +25% +206% 31 Mar 2025
Q4 2024 27% +11% +69% 31 Dec 2024
Q3 2024 20% +4.2% +27% 30 Sep 2024
Q2 2024 16% +3% +23% 30 Jun 2024
Q1 2024 12% +0.65% +5.6% 31 Mar 2024
Q4 2023 16% +8.1% +107% 31 Dec 2023
Q3 2023 16% +9.8% +169% 30 Sep 2023
Q2 2023 13% +7.4% +130% 30 Jun 2023
Q1 2023 12% +6.1% +112% 31 Mar 2023
Q4 2022 7.6% +1.7% +28% 31 Dec 2022
Q3 2022 5.8% -1.4% -20% 30 Sep 2022
Q2 2022 5.7% -5.8% -51% 30 Jun 2022
Q1 2022 5.5% -12% -69% 31 Mar 2022
Q4 2021 5.9% -24% -80% 31 Dec 2021
Q3 2021 7.2% -41% -85% 30 Sep 2021
Q2 2021 11% -25% -69% 30 Jun 2021
Q1 2021 18% -15% -46% 31 Mar 2021
Q4 2020 30% -1.8% -5.7% 31 Dec 2020
Q3 2020 48% +18% +62% 30 Sep 2020
Q2 2020 37% +6.4% +21% 30 Jun 2020
Q1 2020 33% +3.6% +12% 31 Mar 2020
Q4 2019 31% -5.9% -16% 31 Dec 2019
Q3 2019 30% -19% -39% 30 Sep 2019
Q2 2019 30% -30% -50% 30 Jun 2019
Q1 2019 29% -182% -86% 31 Mar 2019
Q4 2018 37% +204% 31 Dec 2018
Q3 2018 49% +120% 30 Sep 2018
Q2 2018 61% +138% 30 Jun 2018
Q1 2018 211% +288% 31 Mar 2018
Q4 2017 -167% -90% -117% 31 Dec 2017
Q3 2017 -71% +61% +46% 30 Sep 2017
Q2 2017 -77% +66% +46% 30 Jun 2017
Q1 2017 -77% +89% +54% 31 Mar 2017
Q4 2016 -77% +278% +78% 31 Dec 2016
Q3 2016 -132% +596% +82% 30 Sep 2016
Q2 2016 -143% -1870% -108% 30 Jun 2016
Q1 2016 -167% -503% -150% 31 Mar 2016
Q4 2015 -355% -652% -219% 31 Dec 2015
Q3 2015 -728% -981% -389% 30 Sep 2015
Q2 2015 1727% +1608% +1354% 30 Jun 2015
Q1 2015 336% +220% +190% 31 Mar 2015
Q4 2014 297% 31 Dec 2014
Q3 2014 252% 30 Sep 2014
Q2 2014 119% 30 Jun 2014
Q1 2014 116% 31 Mar 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.